ZLAB logo

Zai Lab Limited (ZLAB)

Profile

Full Name

Zai Lab Limited

Ticker Symbol

ZLAB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

China

IPO

September 20, 2017

Indexes

Not included

Website

http://www.zailaboratory.com

Employees

1869

Key Details

Price

$28.84(-0.33%)

Market cap

$3.12B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$398.99M(+49.59% YoY)

Annual EPS

-$2.60(+25.71% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$28.84
ZLAB price is $28.84

30-Day Relative Volume

0.54
ZLAB 30-day relative volume is 0.54

Price Performance

Price Most recent change

-0.33%
ZLAB price was down -0.33% on Apr 17, 2025

Price YTD change

+10.12%
ZLAB price is up +10.12% since January 1st

Price 1-year change

+110.2%
ZLAB price is up +110.2% year-on-year

Price 3-year change

-35.06%
ZLAB price is down -35.06% over the past 3 years

Price Range

Price All-time high

$193.54
ZLAB price is currently -85.10% below its historical high of $193.54

Price 3-year low

$13.48
ZLAB price is currently +113.95% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.12B
ZLAB market capitalization is $3.12 billion

Market cap 3-year change

-27.07%
ZLAB market capitalization is down -27.07% over the past 3 years

Market cap All-time high

$17.08B
ZLAB market capitalization is currently -81.72% below its historical high of $17.08 billion

Market cap sector rank

87.09%
ZLAB market capitalization is higher than 87.09% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+10.98%
ZLAB shares outstanding is up +10.98% year-on-year

Shares Outstanding 3-Year Change

+12.31%
ZLAB shares outstanding is up +12.31% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.85
ZLAB beta is 0.85

200-day SMA

$26.07
ZLAB price is currently +10.64% above its 200-day simple moving average

50-day SMA

$32.93
ZLAB price is currently -12.42% below its 50-day simple moving average

RSI

42.31
ZLAB 14-day relative strength index is 42.31

Volume

0.54
ZLAB 30-day relative volume is 0.54

ATR

$2.71
ZLAB average true range is $2.71

10-day Historical Volatility

159.54%
ZLAB 10-day historical volatility is 159.54%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$398.99M
ZLAB annual revenue is $398.99 million

Revenue Analysts estimate

$564.60M
ZLAB annual revenue is currently -29.33% lower than the consensus analysts' forecast

Revenue 1-year change

+49.59%
ZLAB annual revenue is up +49.59% year-on-year

Revenue Sector rank

71.78%
ZLAB annual revenue is higher than 71.78% of companies in Healthcare sector

EPS

EPS

-$2.60
ZLAB annual earnings per share is -$2.60

EPS Analysts estimate

-$1.63
ZLAB annual earnings per share is currently +59.43% higher than the consensus analysts' forecast

EPS 1-year change

+25.71%
ZLAB annual earnings per share is up +25.71% year-on-year

EPS Sector rank

33.22%
ZLAB annual earnings per share is higher than 33.22% of companies in Healthcare sector

Profit

Gross profit

$251.13M
ZLAB annual gross profit is $251.13 million

Gross margin

62.94%
ZLAB annual gross profit margin is 62.94%

Operating profit

-$273.95M
ZLAB annual operating income is -$273.95 million

Operating margin

-68.66%
ZLAB annual operating profit margin is -68.66%

Net income

-$257.10M
ZLAB annual net profit is -$257.10 million

Net margin

-64.44%
ZLAB annual net profit margin is -64.44%

Expenses

Total expenses

$672.93M
ZLAB annual total expenses is $672.93 million

Operating expenses

$525.08M
ZLAB annual total operating expenses is $525.08 million

Cost of goods sold

$147.86M
ZLAB annual cost of goods sold is $147.86 million

Selling, general & administrative expenses

$298.74M
ZLAB annual SGA is $298.74 million

Depreciation and amortization

$11.86M
ZLAB annual depreciation & amortization is $11.86 million

Interest expense

$2.25M
ZLAB annual interest expense is $2.25 million

Income tax

$0.00
ZLAB annual income tax is $0.00

EBIT & EBITDA

EBIT

-$254.85M
ZLAB annual earnings before interest & taxes is -$254.85 million

EBITDA

-$242.99M
ZLAB annual EBITDA is -$242.99 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.19B
ZLAB annual total assets is $1.19 billion

Non current assets

$135.27M
ZLAB annual long term assets is $135.27 million

Current assets

$1.05B
ZLAB annual total current assets is $1.05 billion

Cash and cash equivalents

$449.67M
ZLAB annual cash & cash equivalents is $449.67 million

Accounts receivable

$85.18M
ZLAB annual accounts receivable is $85.18 million

Inventory

$39.88M
ZLAB annual inventory is $39.88 million

Liabilities

Total liabilities

$344.86M
ZLAB annual total liabilities is $344.86 million

Long term liabilities

$45.47M
ZLAB annual total long term liabilities is $45.47 million

Current liabilities

$299.38M
ZLAB annual total current liabilities is $299.38 million

Accounts payable

$100.91M
ZLAB annual accounts payable is $100.91 million

Debt

Total debt

$153.47M
ZLAB annual total debt is $153.47 million

Total debt 1-year change

+912.94%
ZLAB annual total debt is up +912.94% year-on-year

Long term debt

$13.71M
ZLAB annual long term debt is $13.71 million

Short term debt

$139.76M
ZLAB annual short term debt is $139.76 million

Equity & Capital

Shareholders equity

$840.90M
ZLAB annual stockholders equity is $840.90 million

Book value

$840.90M
ZLAB annual book value is $840.90 million

Retained earnings

-$2.45B
ZLAB annual retained earnings is -$2.45 billion

Working capital

$751.10M
ZLAB annual working capital is $751.10 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$214.87M
ZLAB annual cash flow from operations is -$214.87 million

Cash from operations 1-year change

-8.42%
ZLAB annual cash flow from operations is down -8.42% year-on-year

Cash from investing

-$375.19M
ZLAB annual cash flow from investing activities is -$375.19 million

Cash from investing 1-year change

-3381.75%
ZLAB annual cash flow from investing activities is down -3381.75% year-on-year

Cash from financing

$349.89M
ZLAB annual cash flow from financing activities is $349.89 million

Cash from financing 1-year change

+5538.97%
ZLAB annual cash flow from financing activities is up +5538.97% year-on-year

CAPEX

CAPEX

$61.52M
ZLAB annual capital expenditures is $61.52 million

CAPEX 1-year change

+624.56%
ZLAB annual capital expenditures is up +624.56% year-on-year

Free Cash Flow

Free cash flow

-$276.39M
ZLAB annual free cash flow is -$276.39 million

Free cash flow 1-year change

-33.74%
ZLAB annual free cash flow is down -33.74% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

62.94%
ZLAB annual gross profit margin is 62.94%

Operating margin

-68.66%
ZLAB annual operating profit margin is -68.66%

Net margin

-64.44%
ZLAB annual net profit margin is -64.44%

ROA & ROE

ROA

-23.14%
ZLAB annual return on assets is -23.14%

ROE

-31.41%
ZLAB annual return on equity is -31.41%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ZLAB price to earnings ratio value is unknown

PE ratio Sector rank

-
ZLAB price to earnings ratio is unknown

PB Ratio

PB ratio

3.71
ZLAB price to book ratio is 3.71

PB ratio Sector rank

77.35%
ZLAB price to book ratio is higher than 77.35% of companies in Healthcare sector

PS Ratio

PS ratio

7.83
ZLAB price to sales ratio is 7.83

PS ratio Sector rank

75.13%
ZLAB price to sales ratio is higher than 75.13% of companies in Healthcare sector

Enterprise value

Enterprise value

$2.83B
ZLAB enterprise value is $2.83 billion

Enterprise value Sector rank

85.05%
ZLAB enterprise value is higher than 85.05% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-11.63
ZLAB EV/EBITDA is -11.63

EV/EBITDA Sector rank

9.48%
ZLAB EV/EBITDA is higher than 9.48% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.51
ZLAB annual current ratio is 3.51

Quick ratio

3.38
ZLAB annual quick ratio is 3.38

Leverage

Debt to equity

0.16
ZLAB annual debt to equity ratio is 0.16

Interest coverage ratio

-113.07
ZLAB annual interest coverage ratio is -113.07

Risk & Stability

Piotroski F-Score

2
ZLAB piotroski f-score is 2

Altman Z-Score

2.92
ZLAB altman z-score is 2.92

Analyst ratings

Recent major analysts updates

Mar 27, 25 Cantor Fitzgerald
Overweight
Mar 13, 25 JP Morgan
Overweight
Mar 7, 25 Scotiabank
Sector Outperform
Mar 3, 25 B of A Securities
Neutral
Oct 25, 24 Cantor Fitzgerald
Overweight
Oct 21, 24 JP Morgan
Overweight
Aug 7, 24 Cantor Fitzgerald
Overweight
Jul 12, 24 JP Morgan
Overweight
Jul 1, 24 Cantor Fitzgerald
Overweight
Jun 25, 24 Cantor Fitzgerald
Overweight

Institutional Ownership

Similar stocks

IRTC logo
iRhythm Technologies (IRTC)
RNA logo
Avidity Biosciences (RNA)
SLNO logo
Soleno Therapeutics (SLNO)
OSCR logo
Oscar Health (OSCR)
AMED logo
Amedisys (AMED)
CRSP logo
CRISPR Therapeutics AG (CRSP)
AKRO logo
Akero Therapeutics (AKRO)
MRUS logo
Merus NV (MRUS)
SHC logo
Sotera Health (SHC)
  • What is the ticker symbol for Zai Lab Limited?
  • Does Zai Lab Limited pay dividends?
  • What sector is Zai Lab Limited in?
  • What industry is Zai Lab Limited in?
  • What country is Zai Lab Limited based in?
  • When did Zai Lab Limited go public?
  • Is Zai Lab Limited in the S&P 500?
  • Is Zai Lab Limited in the NASDAQ 100?
  • Is Zai Lab Limited in the Dow Jones?
  • When was Zai Lab Limited's last earnings report?
  • When does Zai Lab Limited report earnings?
  • Should I buy Zai Lab Limited stock now?

What is the ticker symbol for Zai Lab Limited?

The ticker symbol for Zai Lab Limited is NASDAQ:ZLAB

Does Zai Lab Limited pay dividends?

No, Zai Lab Limited does not pay dividends

What sector is Zai Lab Limited in?

Zai Lab Limited is in the Healthcare sector

What industry is Zai Lab Limited in?

Zai Lab Limited is in the Biotechnology industry

What country is Zai Lab Limited based in?

Zai Lab Limited is headquartered in China

When did Zai Lab Limited go public?

Zai Lab Limited's initial public offering (IPO) was on September 20, 2017

Is Zai Lab Limited in the S&P 500?

No, Zai Lab Limited is not included in the S&P 500 index

Is Zai Lab Limited in the NASDAQ 100?

No, Zai Lab Limited is not included in the NASDAQ 100 index

Is Zai Lab Limited in the Dow Jones?

No, Zai Lab Limited is not included in the Dow Jones index

When was Zai Lab Limited's last earnings report?

Zai Lab Limited's most recent earnings report was on Feb 27, 2025

When does Zai Lab Limited report earnings?

The next expected earnings date for Zai Lab Limited is May 8, 2025

Should I buy Zai Lab Limited stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page